Opinion|Videos|April 1, 2025
Empowering Patients and Addressing Concerns in IUD Placement
Author(s)Lisa Bayer, MD, MPH
Panelists discuss how developing an effective pain management plan for intrauterine device (IUD) insertion requires patient cooperation, thorough medical history review, comprehensive education about procedures and tools, consideration of individualized needs, planning for interventions like sedation or antianxiety medication (which may not always be available), and implementation of trauma-informed care principles to ensure true informed consent and patient autonomy.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- Developing a pain plan involves cooperation with the patient and an examination of their medical history.
- Patient education and autonomy are key to informed consent.
- Interventions like sedation, antianxiety medication, etc, require planning ahead of time and may not be available.
- Patient education strategies encompass visual diagrams of a procedure to learning about the tools that will be used.
- Find out from the patient what works best for them.
- The principles of trauma-informed care
Advertisement
Related to this article
The 16-item Perimenopause Symptom Scale showed strong reliability and validity among 1255 women aged 35 to 59 years in the United States.
Patients with 3 or more adverse pregnancy outcomes had lower odds of postpartum contraceptive use in a PRAMS analysis of 222,412 individuals.
Kanchi Chadha, MD, FACOG, MSCP, supports reconsidering MHT boxed warnings but says the FDA cited no study behind the change.
HRSA will award up to $1 million to a single organization to update the Women's Preventive Services Guidelines through the new WISH program.
Real-world data show maternal RSVpreF vaccination was 82% effective against infant RSV LRTI hospitalization through 3 months.
Soma Mandal, MD, MSCP, says removing MHT boxed warnings is overdue but calls for transparency on the FDA's product-specific rationale.
Peter Hsin, BS, discusses a meta-analysis linking perioperative ketamine to lower early postpartum depressive symptoms after cesarean delivery.
Susan Reed, MD, MPH, MS, and Calbeth C. Alaribe, DMSc, MPH, PA-C, CPCHE, weigh in on FDA boxed warning removals for menopausal hormone therapy.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
What biomarker-guided preeclampsia care could look like
2
Testosterone for women: Global consensus and physiologic dosing
3
Testosterone physiology in women and the long road to approval
4
Testosterone in women: Androgenic adverse events and lab monitoring
5